hVIVO PLC (AIM:HVO), the clinical research group specialising in human challenge trials, will present at the Jefferies Global Healthcare Conference in London on 20 November.
Chief executive Yamin “Mo” Khan is scheduled to speak at 12.30 pm, with the company also holding one-to-one meetings during the event.
The conference, running from 17 to 20 November, is Europe’s largest healthcare investment gathering, featuring more than 700 companies and 10,000 meetings.
hVIVO said no new information would be disclosed, and the presentation will be posted online afterwards.